MK
Mills Kenneth T.
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Mills Kenneth T., 董事长兼首席执行官. Officer active across 1 company, notably REGENXBIO Inc.. Cumulatively, 21 reports have been published. Activity tracked since 24 June 2021. The latest transaction was disclosed on 27 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mills Kenneth T.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
225,000 股@ US$13.0965.9% 占其流量Common StockSEC:0001652824-26-000002:0
7,768 股0Common StockSEC:0001562180-25-004351:0
20,602 股@ US$3.764.9% 占其流量Common StockSEC:0001562180-25-003822:0
30,752 股@ US$3.767.6% 占其流量Common StockSEC:0001562180-25-002804:0
36,316 股@ US$0.852.0% 占其流量Common StockSEC:0001562180-24-006146:0
12,221 股@ US$3.763.0% 占其流量Common StockSEC:0001562180-24-005855:0
200 股@ US$3.760.0% 占其流量Common StockSEC:0001562180-24-005798:0
15,000 股@ US$3.763.7% 占其流量Common StockSEC:0001562180-24-004104:0
15,000 股@ US$3.763.7% 占其流量Common StockSEC:0001562180-24-003452:0
15,000 股@ US$3.763.6% 占其流量Common StockSEC:0001562180-24-002771:0
15,000 股@ US$3.763.7% 占其流量Common StockSEC:0001562180-24-001395:0
45,000 股@ US$3.7610.9% 占其流量Common StockSEC:0001562180-24-000544:0
11,357 股@ US$17.9513.0% 占其流量Common StockSEC:0001562180-24-000223:0
43,500 股@ US$3.7610.5% 占其流量Common StockSEC:0001562180-23-008519:0
9,308 股@ US$22.6813.9% 占其流量Common StockSEC:0001562180-23-000221:0
3,636 股@ US$32.702.8% 占其流量Common StockSEC:0001562180-22-000149:0
3,300 股0Common StockSEC:0001562180-21-007473:0
1,500 股@ US$3.760.1% 占其流量Common StockSEC:0001562180-21-006967:0
1,500 股@ US$3.760.1% 占其流量Common StockSEC:0001562180-21-006147:0
3,000 股@ US$3.760.3% 占其流量Common StockSEC:0001562180-21-005947:0
4,500 股@ US$3.760.4% 占其流量Common StockSEC:0001562180-21-004525:0
About Mills Kenneth T.
Mills Kenneth T. is President-CEO and a director of REGENXBIO Inc. (XNAS). He has filed 21 forms, and the sampled recent filings cover the period from 2021-06-28 to 2026-01-29, with option exercises as the most frequent transaction type.